Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1)
Completed · Phase 3 · Has a placebo group
Conditions studied: Hypertension
In brief
The purpose of this study is to determine the efficacy of clevidipine injection versus placebo in treating preoperative hypertension.
Key facts
- Study ID
- NCT00093249
- Run by
- The Medicines Company
- People needed
- 105
- Starts
- 2004-01-01
- Expected to finish
- 2004-11-01
- Last updated by the study team
- 2014-08-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cardio-Thoracic Surgeons, PC — Birmingham, Alabama, United States
- St Vincent Medical Center — Los Angeles, California, United States
- Discovery Alliance - Hudson — Hudson, Florida, United States
- Discovery Alliance - Sacred Heart Hospital — Pensacola, Florida, United States
- Atlanta VA Medical Center — Atlanta, Georgia, United States
- MacNeal Hospital — Berwyn, Illinois, United States
- Wake Forest University School of Medicine — Winston-Salem, North Carolina, United States
- The Christ Hospital, The Linder Clinical Trial Center — Cincinnati, Ohio, United States
- Memorial Herman Memorial City Hospital — Houston, Texas, United States
- Texas Heart Institute — Houston, Texas, United States
- Houston Northwest Medical Center — Houston, Texas, United States
- Swedish Hospital Medical Center — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.